Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis

This work was funded by a Research Grant 2018 of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grant PTDC/BIA-MIC/31233/2017 awarded to MC.

Detalhes bibliográficos
Autor principal: Catalão, Maria João (author)
Outros Autores: Filipe, Sérgio R. (author), Pimentel, Madalena (author)
Formato: article
Idioma:eng
Publicado em: 2019
Assuntos:
Antibiotic resistance
Cell wall
Mycobacteria
Mycobacteriophage lysis enzymes
Peptidoglycan
Tuberculosis
β-lactams
Microbiology
Microbiology (medical)
SDG 3 - Good Health and Well-being
Texto completo:https://doi.org/10.3389/fmicb.2019.00190
País:Portugal
Oai:oai:run.unl.pt:10362/81794

Texto Completo

https://doi.org/10.3389/fmicb.2019.00190

Registros relacionados